High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome
Martine E.D. Chamuleau(Hovon), G.J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Arjan A. van de Loosdrecht(Dutch Cancer Society), Jeroen J. W. M. Janssen(Radboud University Nijmegen), A. Zevenbergen(Amsterdam UMC Location VUmc), Bob Löwenberg(Unknown), Ruud Delwel(Erasmus MC Cancer Institute), Peter J.M. Valk(Erasmus MC Cancer Institute), C. J. Hess(Amsterdam UMC Location VUmc)
Cited by 85
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k